It’s no secret the world thinks Morning People are better than those of us who dgaf about a sunrise. Never mind that people who own leafblowers and the majority of serial killers are statistically more likely to be early risers. I’ve never been a Morning…

Kesimpta (ofatumumab) was more effective than Aubagio (teriflunomide) at suppressing disease activity in people with highly active, relapsing forms of multiple sclerosis (MS), according to new analyses from the Phase 3 ASCLEPIOS trials. After two years, those on Kesimpta were nearly 20 times more likely…

By Nicole Robinson Living with multiple sclerosis has changed the way I look at a lot of things, especially what it means to celebrate myself. For a long time, I didn’t think of myself as someone who needed to be … Continue reading → Source:…

A new partnership aims to advance software that uses artificial intelligence (AI) to examine brain MRI scans for signs characteristic of multiple sclerosis (MS). Neurophet said it will work with the Vall d’Hebron Institut de Recerca (VHIR), the research institute of Vall d’Hebron University Hospital…